Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
Julián Panés(Hospital Clínic de Barcelona), Andrea Laghi(Humanitas University), Jaap Stoker(University of Amsterdam), Giovanni Maconi(Luigi Sacco Hospital), Robert Ehehalt(University Hospital Heidelberg), Dominik Weishaupt(Triemli Hospital), Fabiana Castiglione, Torsten Kucharzik(Klinikum Lüneburg), Daniel C. Baumgart(University of Alberta), Laurent Peyrin‐Biroulet(Délégation Centre-Est), Giovanni Morana(Ca' Foncello Hospital), Gert Van Assche(KU Leuven), Shaji Sebastian(University of Hull), Silvio Danese(IRCCS Ospedale San Raffaele), Douglas Pendsé(University College Hospital), Jordi Rimola(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Fernando Magro(Universidade do Porto), Damian Tolan(Leeds General Infirmary), Celso Matos(Champalimaud Foundation), Gerhard Rogler(University Hospital of Zurich), J. Martín-Comín(Bellvitge University Hospital), Francesca Maccioni(Sapienza University of Rome), Ahmed Ba‐Ssalamah(Medical University of Vienna), Davide Bellini, Yoram Bouhnik(Clinique Ambroise Paré), Maria Antonietta Bali(Royal Marsden NHS Foundation Trust), Sandro Ardizzone(European CanCer Organisation), Alberto Signore(CTO Andrea Alesini), Bart M. Wiarda(Medisch Centrum Alkmaar), Roberto Grassi(University of Campania "Luigi Vanvitelli"), Borut Marinček(Case Western Reserve University), Livia Biancone(University of Rome Tor Vergata), Walter Reinisch(Medical University of Vienna), Steve Halligan(University College London), Jeroen A. W. Tielbeek(Amsterdam UMC Location University of Amsterdam), Stuart A. Taylor(Brighton and Sussex Medical School)
Cited by 669
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Crohn's disease
|The Lancet|2012|2.1k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k